[ad_1] About half of the American public has heard little or nothing about the new…
BioNTech SE ADR
-
-
STOCK MARKET
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
by userby user[ad_1] Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization…
-
STOCK MARKET
Moderna expects the shortage of its updated COVID-19 booster to soon be resolved
by userby user[ad_1] Moderna Inc. MRNA, -3.04% said Wednesday that it expects to resolve supply issues for…
-
[ad_1] U.S. stocks flipped between gains and losses on Monday as investors braced for a…
-
STOCK MARKET
Moderna sets up clash with Pfizer and BioNTech with patent lawsuits in the U.S. and Germany
by userby user[ad_1] Moderna Inc. on Friday filed lawsuits against Pfizer Inc. and German partner BioNTech SE,…
-
STOCK MARKET
Omicron-targeting COVID boosters may be out after Labor Day, and Moderna has joined Pfizer and BioNTech in filing for authorization
by userby user[ad_1] Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor…
-
[ad_1] Americans age 12 and older could begin getting omicron-specific COVID-19 boosters soon after Labor…
-
STOCK MARKET
Jill Biden leaves isolation after twice testing negative, and Novavax vaccine is now allowed for U.S. teens
by userby user[ad_1] First lady Jill Biden left isolation on Sunday, after testing negative for COVID twice…
-
STOCK MARKET
What will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out
by userby user[ad_1] Get ready for a big change in how the U.S. will pay for COVID-19…
-
STOCK MARKET
U.K. regulator is first to authorize Moderna’s bivalent COVID booster for adults aged 18 and older
by userby user[ad_1] The U.K. regulator has become the first to authorize Moderna’s bivalent COVID vaccine booster…